Potassium Iodide → HCID 19422752, compound
Reaction equation
[C:1](=[O:44])([O:6][CH2:7][CH2:8][N:9]([C:41](=[O:43])[CH3:42])[C:10]1[C:15]([I:16])=[C:14]([C:17]([N:19]([CH:21]2[CH2:25][O:24][C:23]([CH3:27])([CH3:26])[O:22]2)[CH3:20])=[O:18])[C:13]([I:28])=[C:12]([C:29]([N:31]([CH:33]2[CH2:37][O:36][C:35]([CH3:39])([CH3:38])[O:34]2)[CH3:32])=[O:30])[C:11]=1[I:40])[O:2][CH:3](Cl)[CH3:4].[C:45]([NH:48][C:49]1[C:50]([I:65])=[C:51]([N:60]([C:62](=[O:64])[CH3:63])[CH3:61])[C:52]([I:59])=[C:53]([C:56]([O-:58])=[O:57])[C:54]=1[I:55])(=[O:47])[CH3:46].[K+].[I-].[K+]>CN(C=O)C>[C:45]([NH:48][C:49]1[C:50]([I:65])=[C:51]([N:60]([C:62](=[O:64])[CH3:63])[CH3:61])[C:52]([I:59])=[C:53]([C:56]([O:58][CH:3]([O:2][C:1]([O:6][CH2:7][CH2:8][N:9]([C:41](=[O:43])[CH3:42])[C:10]2[C:15]([I:16])=[C:14]([C:17]([N:19]([CH:21]3[CH2:25][O:24][C:23]([CH3:27])([CH3:26])[O:22]3)[CH3:20])=[O:18])[C:13]([I:28])=[C:12]([C:29]([N:31]([CH:33]3[CH2:37][O:36][C:35]([CH3:39])([CH3:38])[O:34]3)[CH3:32])=[O:30])[C:11]=2[I:40])=[O:44])[CH3:4])=[O:57])[C:54]=1[I:55])(=[O:47])[CH3:46]Participants
Conditions
- Temperature
- 50 °C
Procedure
1-Chloroethyl 2-(N-(3,5-bis-((2,2-dimethyl-1,3-dioxolan-4-yl)-methylaminocarbonyl)-2,4,6-triiodophenyl)-acetylamino)ethyl carbonate (3.1 g, 3.3 mmol) was added at room temperature to a solution of potassium 5-(N-acetylamino)-3-(N-acetyl-N-methylamino)-2,4,6-triiodobenzenecarboxylate (2.00 g, 3 mmol) and potassium iodide (50 mg, 0.3 mmol) in dry DMF. After stirring at 50° C. for 18 hours and at room temperature for one day the solvent was removed at reduced pressure. The residue was suspended in chloroform (50 ml) and DMF (5 ml) and washed twice with a sodium hydrogen carbonate solution and twice with water. After treatment of the organic phase with magnesium sulfate and charcoal the solution was evaporated to dryness. Yield: 2.65 g. FAB-MS: M+1=1528.
Workup
- customwas removed at reduced pressure
- washDMF (5 ml) and washed twice with a sodium hydrogen carbonate solution and twice with water
- customAfter treatment of the organic phase with magnesium sulfate and charcoal the solution was evaporated to dryness
Sources & evidence
- ORD record
- ord-0373958e2e02452fa122d84cc5d9b4d9
- Source dataset
- uspto-grants-1996_09
- Patent number
- US05559266
Reaction notes
Loading…